Cartesian Therapeutics, Inc. (RNAC) — DEF 14A Filings
All DEF 14A filings from Cartesian Therapeutics, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Cartesian Therapeutics Files Proxy Statement for Annual Meeting
— Aug 16, 2024 Risk: medium
Cartesian Therapeutics, Inc. filed a DEF 14A on August 16, 2024, for its annual meeting on September 20, 2024. The filing concerns the company's proxy statement -
Cartesian Therapeutics, Inc. Files Definitive Proxy Statement
— Apr 26, 2024 Risk: low
Cartesian Therapeutics, Inc. (RNAC) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Filing is a Definitive Proxy Statement (DEF 14A) for Carte -
Cartesian Therapeutics, Inc. Announces Special Meeting of Stockholders
— Feb 14, 2024 Risk: medium
Cartesian Therapeutics, Inc. (RNAC) filed a Proxy Statement (DEF 14A) with the SEC on February 14, 2024. Special meeting of stockholders to be held on March 27,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX